A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases

Krishnakumar Menon, David L Steer, Martin Short, Steven Petratos, Ian M Smyth, Claude CA Bernard

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)


Neurodegenerative diseases, such as multiple sclerosis represent global health issues. Accordingly, there is an urgent need to understand the pathogenesis of this and other central nervous system disorders, so that more effective therapeutics can be developed. Cerebrospinal fluid is a potential source of important reporter molecules released from various cell types as a result of central nervous system pathology. Here, we report the development of an unbiased approach for the detection of reactive cerebrospinal fluid molecules and target brain proteins from patients with multiple sclerosis. To help identify molecules that may serve as clinical biomarkers for multiple sclerosis, we have biotinylated proteins present in the cerebrospinal fluid and tested their reactivity against brain homogenate as well as myelin and myelin-axolemmal complexes. Proteins were separated by two-dimensional gel electrophoresis, blotted onto membranes and probed separately with biotinylated unprocessed cerebrospinal fluid samples. Protein spots that reacted to two or more multiple sclerosis-cerebrospinal fluids were further analyzed by MALDI-TOF-TOF mass spectrometry. In addition to previously reported proteins found in multiple sclerosis-cerebrospinal fluid, such as alpha beta crystallin, enolase, and 14-3-3-protein, we have identified a number of additional molecules involved in mitochondrial/energy metabolism, myelin gene expression and/or cytoskeletal organization. These include, aspartate aminotransferase,..
Original languageEnglish
Pages (from-to)1 - 14
Number of pages14
JournalMolecular & Cellular Proteomics
Issue number6 (Art. ID: M110.000042)
Publication statusPublished - 2011

Cite this